Imatinib Completed Phase 3 Trials for Pulmonary Arterial Hypertension (PAH) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00902174Imatinib (QTI571) in Pulmonary Arterial Hypertension